1. Volume 85, Issue 3, Pages 636-640 (March 2014)
The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis 
Björn Meijers, Rutger J.H. Maas, Ben Sprangers, Kathleen Claes, Ruben Poesen, Bert Bammens, Maarten Naesens, Jeroen K.J. Deegens, Ruth Dietrich, Markus Storr, Jack F.M. Wetzels, Pieter Evenepoel, Dirk Kuypers 
Kidney International 
Volume 85, Issue 3, Pages (March 2014)
DOI: /ki
Copyright © 2014 International Society of Nephrology Terms and Conditions

2. Figure 1
Circulating soluble urokinase receptor (suPAR) in patients with chronic kidney disease (CKD). (a) suPAR concentrations according to strata of estimated glomerular filtration rate (eGFR). (b–d) suPAR concentrations plotted as a function of the eGFR for non-focal segmental glomerulosclerosis (FSGS) controls (black dots), patients with active FSGS (red dots), and FSGS in remission (green dots). Data are plotted for all patients (a, b) for patients with 24-h proteinuria more than 1g, (c) and for patients with a 24-h proteinuria exceeding 3g.
Kidney International  , DOI: ( /ki )
Copyright © 2014 International Society of Nephrology Terms and Conditions